Clinical trial · Interventional
Perioperative Application of Omega-3 Polyunsaturated Fatty Acids in Gastric Cancer Patients
Efficacy of Perioperative Application of Omega-3 Polyunsaturated Fatty Acids on Postoperative Immunization in Gastric Cancer Patients - A Prospective, Randomized Clinical Trial
NCT01910948CI-TRIAL-00011515PAOPUFAGCunknownPhase 4ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
To evaluate immunomodulatory effects of perioperative application of omega-3 polyunsaturated fatty acids in gastric cancer surgery, the effects of postoperative recovery, the improvement of nutritional status, incidence rate of related complications, and whether it can reduce the average postoperative hospitalization days.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Gastric Cancer | Malignant Gastric Neoplasm | CURATED_BROADER | 0.80 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| omega-3 polyunsaturated fatty acids | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- omega-3 polyunsaturated fatty acids
- description
- The included patients will be randomly divided into two groups A and B, two groups of patients 4 days before operation begin to give parenteral nutrition: A: the control group of normal intravenous nutrition. B: the trial group,add omega-3 polyunsaturated fatty acids 0.2 g/kg to parenteral nutrition, no use on the day of surgery, postoperative 2 days continue to add omega-3 polyunsaturated fatty acids 0.2 g/kg.
- interventionNames
- Drug: omega-3 polyunsaturated fatty acids
Primary outcomes (1)
- measure
- blood immune factors
- timeFrame
- 10 days
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 85 Years
Show eligibility criteria text
Inclusion Criteria: * Patients coming to FirstJilinU diagnosed gastric cancer by endoscopy and pathology. * No preoperative treatment, the gastric cancer radical surgery in our hospital is the first treatment. * Nutrition screening score (NRS 3 or higher). * Albumin and (or) immune enhancer were not used within two weeks before operation . * No blood system diseases. Exclusion Criteria: * Being in the acute phase of inflammation before operation and emergency surgery. * Patients combined metabolic diseases such as diabetes, hyperthyroidism, immune system disease or taking immunosuppressants; * Combined hepatic insufficiency. * Spleen resected in operation
References
Publications (0)
Data not yet available
No reference posted for this study.